Certain type of cancer drugs that promote the death of cells can actually be harmful if combined with other treatments that damage our DNA, RNA or proteins, researchers have found.
Clinical and Molecular Medicine
Chronic intestinal inflammation requires special individualized treatment. Finding the right treatment for each person may soon become easier.
One combination of two drugs was so effective that researchers hope others can begin clinical trials on the drugs now.
CT screening to detect lung cancer can save lives. The challenge is to find out who should undergo CT scans. A new method more accurately identifies the right individuals in the risk zone.
NTNU researchers recently figured out a whole new method for testing people for the coronavirus. The university is now producing tests on a continuous basis, under the auspices of the Norwegian Directorate of Health. Currently 100 000 tests a day are being manufactured, with production soon likely to be scaled up dramatically.
Norway’s Ministry of Health and Care Services confirmed Friday that it will roll out coronavirus test kits developed by researchers from NTNU and St Olavs Hospital by the last week of April/early May. The kits will more than triple Norway’s testing capacity during the rollout.
There’s no effective treatment for the coronavirus that causes COVID-19, which was first detected in Wuhan, China. Developing new drugs and vaccines can take years. Existing drugs offer a possible quick response to the potential pandemic.
Even the best chef can make mistakes – even when using the recipes (genes) from the “cookbook of life” — DNA. A new discovery as to how cells repair their DNA may have implications for the future drug development.
Metformin significantly reduces the risk of late miscarriages and preterm births for women with PCOS. But the drug does not work to prevent gestational diabetes, according to a large Nordic study from NTNU and St. Olavs hospital.